Small stress molecules inhibit aggregation and neurotoxicity of prion peptide 106-126

Biochemical and Biophysical Research Communications

Volumn 365, Issue 4, 2008, Pages 808-813

  Kanapathipillai, Mathumai ^a   Ku, Sook Hee ^b   Girigoswami, Koyeli ^b   Park, Chan Beum ^a,b  

^a Arizona State University   (United States)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Cytotoxicity; Ectoine; Mannosylglyceramide; Prion; Small stress molecules

Indexed keywords

PRION PEPTIDE 106-126; PRION PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN AGGREGATION;

AMINO ACIDS, DIAMINO; BINDING SITES; CELL LINE; CELL SURVIVAL; GALACTOSYLCERAMIDES; HUMANS; MULTIPROTEIN COMPLEXES; NEURONS; NEUROTOXINS; PEPTIDE FRAGMENTS; PRIONS; PROTEIN BINDING;

EID: 37049023410     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.074     Document Type: Article

References (30)

1. Aguzzi A., and Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 116 (2004) 313-327
2. Prusiner S.B. Prion diseases and the BSE crisis. Science 278 (1997) 245-251
3. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. USA 95 (1998) 13363-13383
4. Kuwahara C., Takeuchi A.M., Nishimura T., Haraguchi K., Kubosaki A., Matsumoto Y., Saeki K., Matsumoto Y., Yokoyama T., Itohara S., and Onodera T. Prions prevent neuronal cell-line death. Nature 400 (1999) 225-226
5. Harris D.A., and True H.L. New insights into prion structure and toxicity. Neuron 50 (2006) 353-357
6. Jobling M.F., Stewart L.R., White A.R., McLean C., Friedhuber A., Maher F., Beyreuther K., Masters C.L., Barrow C.J., Collins S.J., and Cappai R. The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126. J. Neurochem. 73 (1999) 1557-1565
7. Salmona M., Malesani P., De Gioia L., Gorla S., Bruschi M., Molinari A., Della Vedova F., Pedrotti B., Marrari M.A., Awan T., Bugiani O., Forloni G., and Tagliavini F. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. Biochem. J. 342 (1999) 207-214
8. Tagliavini F., Prelli F., Verga L., Giaccone G., Sarma R., Gorevic P., Ghetti B., Passerini F., Ghibaudi E., Forloni G., Salmona M., Bugiani O., and Frangione B. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA 90 (1993) 9678-9682
9. De Gioia L., Selvaggini C., Ghibaudi E., Diomede L., Bugiani O., Forloni G., Tagliavini F., and Salmona M. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. J. Biol. Chem. 269 (1994) 7859-7862
10. Pan K.-M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., and Prusiner S.B. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90 (1993) 10962-10966
11. Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O., and Tagliavini F. Neurotoxicity of a prion protein fragment. Nature 362 (1993) 543-546
12. Selvaggini C., De Gioia L., Cantu L., Ghibaudi E., Diomede L., Passerini F., Forloni G., Bugiani O., Tagliavani F., and Salmona M. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Res. Commun. 194 (1993) 1380-1386
13. Brown D.R., Schmidt B., and Kretzschmar H.A. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380 (1996) 345-347
14. Lippert K., and Galinski E.A. Enzyme stabilization by ectoine-type compatible solutes- protection against heating, freezing and drying. Appl. Microbiol. Biotechnol. 37 (1992) 61-65
15. Lentzen G., and Schwarz T. Extremolytes: natural compounds from extremophiles for versatile applications. Appl. Microbiol. Biotechnol. 72 (2006) 623-634
16. Nunes O.C., Manaia C.M., Da Costa M.S., and Santos H. Compatible solutes in the thermophilic bacteria Rhodothermus marinusand Thermus thermophilus. Appl. Environ. Microbiol. 61 (1995) 2351-2357
17. Santos H., and Da Costa M.S. Organic solutes from thermophiles and hyperthermophiles. Methods Enzymol. 334 (2001) 302-315
18. Arora A., Ha C., and Park C.B. Inhibition of insulin amyloid formation by small stress molecules. FEBS Lett. 564 (2004) 121-125
19. Kanapathipillai M., Lentzen G., Sierks M., and Park C.B. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid. FEBS Lett. 579 (2005) 4775-4780
20. Goller K., and Galinski E.A. Protection of a model enzyme (lactate dehydrogenase) against heat, urea and freeze-thaw treatment by compatible soluted additive. J. Mol. Catal. B: Enzymol. 7 (1999) 37-45
21. Andersson M.M., Breccia J.D., and Hatti-Kaul R. Stabilizing effect of chemical additives against oxidation of lactate dehydrogenase. Biotechnol. Appl. Biochem. 32 (2000) 145-153
22. Barth S., Huhn M., Matthey B., Klimka A., Galinski E.A., and Engert A. Compatible-solute-supported periplasmic expression of functional recombinant proteins under stress conditions. Appl. Environ. Microbiol. 66 (2000) 1572-1579
23. Borges N., Ramos A., Raven N.D.H., Sharp R.J., and Santos H. Comparative study of the thermostabilizing properties of mannosylglycerate and other compatible solutes on model enzymes. Extremophiles 6 (2002) 209-216
24. Knapp S., Landenstein R., and Galinski E.A. Extrinsic protein stabilization by naturally occurring osmolytes β-hydroxyectoine and betaine. Extremophiles 3 (1999) 191-198
25. Martins L.O., and Santos H. Accumulation of mannosylglycerate and di-myo-inositol-phosphate by Pyrococcus furiosus in response to salinity and temperature. Appl. Environ. Microbiol. 61 (1995) 3299-3303
26. Silva Z., Borges N., Martins L.O., Wait R R., Da Costa M.S., and Santos H. Combined effect of the growth temperature and salinity of the medium on the accumulation of compatible solutes by Rhodothermus marinus and Rhodothermus obamensis. Extremophiles 3 (1999) 163-172
27. Stine W.B., Snyder S.W., Lardor U.S., Wade W.S., Miller M.F., Perun T.J., Holzman T.F., and Krafft G.A. The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy. J. Protein Chem. 15 (1996) 193-203
28. Shearman M.S., Hawtin S.R., and Tailor V.J. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. J. Neurochem. 65 (1995) 218-227
29. Nielsen L., Khurana R., Coats A., Frokjaer S., Brange J., Vyas S., Uversky V.N., and Fink A.L. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40 (2001) 6036-6046
30. Kuwata K., Matumono T., Cheng H., Nagayama K., James T.L., and Roder H. NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106-126. Proc. Natl. Acad. Sci. USA 100 (2003) 14790-14795